🇺🇸 Silgard in United States
80 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 80
Most-reported reactions
- Anxiety — 8 reports (10%)
- Arthralgia — 8 reports (10%)
- Asthenia — 8 reports (10%)
- Dizziness — 8 reports (10%)
- Fatigue — 8 reports (10%)
- Fibromyalgia — 8 reports (10%)
- General Physical Health Deterioration — 8 reports (10%)
- Memory Impairment — 8 reports (10%)
- Migraine — 8 reports (10%)
- Myalgia — 8 reports (10%)
Silgard in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Silgard approved in United States?
Silgard does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Silgard in United States?
Ruth Tachezy, PhD. is the originator. The local marketing authorisation holder may differ — check the official source linked above.